Cite
Markov SD, Caffrey TC, O'Connell KA, et al. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer. Mol Cancer Ther. 2021;20(12):2457-2468doi: 10.1158/1535-7163.MCT-21-0368.
Markov, S. D., Caffrey, T. C., O'Connell, K. A., Grunkemeyer, J. A., Shin, S., Hanson, R., Patil, P. P., Shukla, S. K., Gonzalez, D., Crawford, A. J., Vance, K. E., Huang, Y., Eberle, K. C., Radhakrishnan, P., Grandgenett, P. M., Singh, P. K., Madiyalakan, R., Daniels-Wells, T. R., Penichet, M. L., Nicodemus, C. F., Poole, J. A., Jaffee, E. M., Hollingsworth, M. A., & Mehla, K. (2021). IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer. Molecular cancer therapeutics, 20(12), 2457-2468. https://doi.org/10.1158/1535-7163.MCT-21-0368
Markov, Spas Dimitrov, et al. "IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer." Molecular cancer therapeutics vol. 20,12 (2021): 2457-2468. doi: https://doi.org/10.1158/1535-7163.MCT-21-0368
Markov SD, Caffrey TC, O'Connell KA, Grunkemeyer JA, Shin S, Hanson R, Patil PP, Shukla SK, Gonzalez D, Crawford AJ, Vance KE, Huang Y, Eberle KC, Radhakrishnan P, Grandgenett PM, Singh PK, Madiyalakan R, Daniels-Wells TR, Penichet ML, Nicodemus CF, Poole JA, Jaffee EM, Hollingsworth MA, Mehla K. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer. Mol Cancer Ther. 2021 Dec;20(12):2457-2468. doi: 10.1158/1535-7163.MCT-21-0368. Epub 2021 Oct 08. PMID: 34625505.
Copy
Download .nbib